We are live on ! Find out more
ALXO icon

ALX Oncology
ALXO

Fund managers haven’t disclosed any holdings of ALXO yet.

ALXO Hedge Fund Activity: Q1 2026 in Review

69 of the 8,128 institutional investors tracked by Wall St. Rank reported a position in ALX Oncology (ALXO) for Q1 2026, worth a combined $189M — up 465% from $33.5M a quarter earlier.

Buyers outnumbered sellers: 25 funds opened new ALXO positions and 12 closed out — a net gain of 13 holders — while 18 added to existing stakes and 11 trimmed.

The largest buyer was RA Capital Management, opening a new position worth an estimated $24.8M. The largest seller was Millennium Management, cutting an estimated $2.32M.

  • 69 institutional investors held ALX Oncology (ALXO) as of Q1 2026, up from 57 in Q4 2025.
  • Funds reported $189M of ALX Oncology stock for Q1 2026, up 465% quarter-over-quarter.
  • 25 funds opened new ALX Oncology positions in Q1 2026 and 12 closed out, a net change of +13 holders.
  • The largest ALX Oncology buyer in Q1 2026 was RA Capital Management, an estimated $24.8M added.
  • The largest ALX Oncology seller in Q1 2026 was Millennium Management, an estimated $2.32M sold.

Based on aggregated 13F filings for Q1 2026.